“Phase I study of single-agent and combined checkpoint inhibition after allogeneic hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence

Sponsor
Hackensack UMC

Protocol Number
Hackensack UMC CPIT Trial 002

To Learn More Call
201-510-0910